Clinical imaging software
CoroLogic is building an on-prem edge platform that restores lower-frame-rate coronary cine through a zero-click DICOM workflow — designed for existing cath labs, no hardware changes.
Fewer frames acquired = less radiation, but jerky motion
AI fills the gaps — smooth motion restored, half the dose
Dose reduction in coronary angiography has stalled at the hardware level. CoroLogic is building the software layer that closes the gap — acquire less, reconstruct what clinicians need to see.
Why now
Interventional cardiologists absorb more cumulative radiation than nearly any other medical specialty. The demand for dose reduction is not new — but the available tools have stalled.
Lowering the frame rate is the simplest lever to cut dose. But it destroys the temporal fidelity clinicians depend on for diagnosis and intervention. So in practice, most operators default back to high-dose protocols.
Detector upgrades and tube filtering from GE, Philips, and Siemens have plateaued. The gains left on the table are not in hardware — they are in what software can reconstruct after acquisition.
Clinicians choose between patient safety and diagnostic confidence. Lower frame rate means less radiation — but also jerky, unreliable motion.
Flat-panel detector improvements and X-ray tube refinements have reached diminishing returns. The next meaningful reduction will come from software.
Acquire at a physically lower frame rate, then restore the missing temporal information with generative AI. The dose drops. The diagnostic quality stays.
How it works in a cath lab
Who it's for
Reduce radiation exposure for patients and staff without compromising diagnostic image quality. Integrates into existing DICOM workflows with no hardware changes — works with GE, Philips, Siemens, and Canon systems.
Request a pilot assessmentEmbed AI-driven frame restoration into your angiography platform. A licensable software module that extends your dose-reduction capabilities beyond hardware limits.
Explore integration optionsGenerative AI meets interventional cardiology — a regulated, high-value market with clear clinical need and validated retrospective evidence at scale.
See our investment thesisEvidence
Single-institution retrospective study at Seoul National University Bundang Hospital. All metrics from completed validation on real patient data.
Engineering targets for the Frame AI'D product prototype. Design goals under active development, not yet validated in a clinical setting.
Planned regulatory submissions and clinical studies. Timelines subject to regulatory processes.
From research to product
Team, Origin & IP
CoroLogic was founded to translate a large-scale clinical imaging research program into a deployable product — combining physician-led problem definition, deep learning system design, and commercial execution.
Co-founder & CEO
MBA, Indiana University. Commercial strategy and partnerships.
Co-founder & CMO
Interventional cardiologist, SNUBH. Original research direction.
Co-founder & CTO
11+ years angiography systems, Siemens & Canon. Model development.
Get in touch
Whether you are evaluating a pilot, exploring OEM integration, or looking at the investment case — we would like to hear from you.
